# Early Initiated Vasopressor Therapy in the Emergency Department

> **NCT05931601** · PHASE3 · RECRUITING · sponsor: **Odense University Hospital** · enrollment: 320 (estimated)

## Conditions studied

- Shock
- Shock, Septic
- Hypotension
- Hypotension and Shock
- Hypotension Symptomatic
- Hypovolemia
- Hypovolemic Shock
- Hypovolemic

## Interventions

- **DRUG:** Noradrenaline

## Key facts

- **NCT ID:** NCT05931601
- **Lead sponsor:** Odense University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-08
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-01-31
- **Target enrollment:** 320 (ESTIMATED)
- **Last updated:** 2025-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05931601

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05931601, "Early Initiated Vasopressor Therapy in the Emergency Department". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05931601. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
